Research Article
A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
| | Hazard ratio | value | 95% CI |
| Discharge status (dead vs. alive) | 0.53 | 0.042 | 0.29–0.97 | Requirement of mechanical ventilation on discharge status | 2.32 | 0.005 | 1.28–4.19 |
|
|